ROBITUSSIN COMPLETE NIGHTTIME

pfizer consumer healthcare a division of pfizer canada ulc🇨🇦 Health Canada

Approval Id: 56ee93dff7e0b8b3
Drug Approval Canada Name: ROBITUSSIN COMPLETE NIGHTTIME
Product Name: ROBITUSSIN COMPLETE NIGHTTIME
Status: Cancelled Post Market
Status Date: 2019-08-31
Original Market Date: 2017-09-15
Din: 02449188
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: OTC
Ahfs: 48:08.00
Atc Original: N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name: n 02 be 51
Aig Number: 0351552003
Company Name: pfizer consumer healthcare a division of pfizer canada ulc
Company Address: 55 Standish Court, Suite 450, Mississauga, Ontario, Canada, L5R 4B2

DEXTROMETHORPHAN HYDROBROMIDE

15 MG

ACETAMINOPHEN

325 MG

DOXYLAMINE SUCCINATE

6.25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

56ee93dff7e0b8b3

Type

Standard